Prem N Yadav | Neuroscience | Best Researcher Award

Dr. Prem N Yadav | Neuroscience | Best Researcher Award

Senior Principal Scientist, at CSIR-Central Drug Research Institute, India.

Dr. Prem N. Yadav is a distinguished neuroscientist and pharmacologist specializing in opioid receptor modulation, neuropharmacology, and drug discovery. Currently serving as a Senior Principal Scientist & Head at the Division of Neuroscience & Ageing Biology, CSIR-CDRI, he has made significant contributions to neuropsychiatric disorder research. His work spans molecular pharmacology, receptor biology, and translational neuroscience. With extensive postdoctoral research experience in the USA, Dr. Yadav has played a pivotal role in advancing pharmacological interventions for mental health disorders. He is a recipient of prestigious awards, including the Ramanujan Fellowship, and has published extensively in high-impact journals. 📚🔬

Professional Profile

Scopus

ORCID

Google Scholar

Education 🎓

Dr. Yadav holds a Ph.D. in Immunopharmacology from SGPGIMS, Lucknow (2002) and an M.Sc. in Biochemistry from Lucknow University (1996). His academic foundation in immunopharmacology and biochemistry has shaped his research in neuropharmacology, particularly in understanding receptor mechanisms and developing therapeutic strategies for neurological disorders. His interdisciplinary expertise bridges molecular biology and pharmacological innovation.

Experience 👨‍🔬

Dr. Yadav has over two decades of experience in pharmacology and neuroscience. He has held significant research positions, including:

  • Senior Principal Scientist & Head (2021-Present) at CSIR-CDRI’s Neuroscience & Ageing Biology Division.
  • Principal Scientist (2016-2021) at CSIR-CDRI, leading groundbreaking studies on opioid receptors.
  • Research Associate (2007-2011) at the University of North Carolina, focusing on neuropharmacological mechanisms.
  • Post-Doctoral Fellow (2002-2007) at New Jersey Medical School, contributing to receptor biology research. His work continues to impact neuropsychiatric drug development and receptor-targeted therapies.

Research Interests 🔍

Dr. Yadav’s research focuses on opioid receptor pharmacology, drug discovery, and neuropsychiatric disorders. His studies explore GPCR signaling, receptor modulation, and epigenetic mechanisms in depression. He aims to develop novel therapeutics for neurodegenerative diseases and psychiatric conditions by leveraging pharmacological and biochemical insights. His contributions include pioneering research on kappa-opioid receptors, serotonin receptor modulators, and neuroplasticity mechanisms.

Awards 🏆

Dr. Yadav has received numerous accolades for his contributions to neuroscience and pharmacology, including:

  • Ramanujan Fellowship (2012-2017) – Supporting independent research careers for distinguished scientists.
  • Young Scientist Award (2010) – Recognized by the Serotonin Club, Montreal, Canada.
  • Travel Award (2006) – For presenting research at the International Narcotic Research Conference, St. Paul, MN. These honors highlight his influence in pharmacology and neuroscience.

Top Noted Publications đź“–

Dr. Yadav has authored over 60 high-impact publications in prestigious journals. Notable works include:

  • “Kappa Opioid Receptor Activation Induces Epigenetic Silencing of Brain-Derived Neurotropic Factor via HDAC5 in Depression.” Published in ACS Chemical Neuroscience, August 2024.

    Authors: Anubhav Yadav, Shalini Dogra, Arun Kumar Boda, Poonam Kumari, Ajeet Kumar, M. Dash, and Prem N. Yadav.

    Summary: This study explores the role of central kappa opioid receptor (KOR) activation in depression. The researchers found that sustained KOR activation leads to depression-like symptoms in mice by epigenetically silencing brain-derived neurotrophic factor (BDNF) expression in the prefrontal cortex via HDAC5. These findings provide insights into how KOR activation contributes to major depressive disorders.

  • “Discovery and Structure–Activity Relationships of 2,4,5-Trimethoxyphenyl Pyrimidine Derivatives as Selective D5 Receptor Partial Agonists.” Published in Bioorganic Chemistry, September 2024.

    Authors: Sakesh Kumar, Sumit K. Rastogi, Subrata Roy, Kajal Sharma, Santosh Kumar, Debalina Maity, Diwan Chand, Sachin Vishwakarma, Jiaur Gayen, Kinshuk Raj Srivastava, Ravindra Kumar, and P. N. Yadav.

    Summary: The researchers designed and synthesized forty non-catecholamine-based pyrimidine derivatives and identified four as selective D5 receptor partial agonists. Among them, compound 5c (4-(4-bromophenyl)-6-(2,4,5-trimethoxyphenyl)pyrimidin-2-amine) exhibited modest D5 receptor agonist activity, as demonstrated using a cAMP-based GloSensor assay in HEK293T cells.

  • “Baicalein Isolated from Oroxylum Indicum Acts as a Potent µ- and Îş-Opioid Receptor Antagonist.” Published in Natural Product Research, 2024.

    Authors: Information not available from the provided sources.

    Summary: Specific details about this study are not available in the provided sources.

  • “Molecular Mechanism of Distinct Chemokine Engagement and Functional Divergence of the Human Duffy Antigen Receptor.” Published in Cell, 2023.

    Authors: Information not available from the provided sources.

    Summary: Specific details about this study are not available in the provided sources.

  • “An Amide to Thioamide Substitution Improves the Permeability and Bioavailability of Macrocyclic Peptides.” Published in Nature Communications, 2023.

    Authors: Information not available from the provided sources.

    Summary: Specific details about this study are not available in the provided sources.

Conclusion

Dr. Prem N. Yadav is a highly accomplished scientist with significant contributions to neuropharmacology, opioid receptor research, and medicinal chemistry. His leadership at CSIR-CDRI, prestigious fellowships, and impactful publications make him an excellent candidate for the Best Researcher Award. Strengthening industry collaborations, patent filings, and national awards would further elevate his credentials.

Fusun Kilic | Serotonin signaling | Best Extension Activity Award

Dr. Fusun Kilic | Serotonin signaling | Best Extension Activity Award 

Doctorate, at RETIRED, United States.

Dr. Fusun Kilic is a retired Professor of Biochemistry and Cellular Molecular Biology with a distinguished career spanning over three decades. Her expertise includes kinetic measurements of transporters, membrane protein modification, and protein-protein interactions. Her pioneering research focused on serotonin (5-HT) signaling, particularly its role in remodeling cell surface N-glycans and post-translational modifications of serotonin transporters (SERT). Dr. Kilic has trained numerous MD/Ph.D. students, published extensively, and received prestigious awards such as the Red Sash and Mentor Awards. She also organized and chaired the 2017 Keystone Symposium “Frontier of Serotonin Beyond the Brain.”

Profile

Scopus

Google Scholar

🎓 Education

Dr. Kilic’s academic journey reflects a dedication to excellence. She completed her Ph.D. in Biochemistry, where she developed an interest in membrane transport proteins and cellular signaling mechanisms. During her postdoctoral training at Yale University, she made groundbreaking contributions to understanding SERT oligomerization and functional consequences. Throughout her career, Dr. Kilic combined her deep biochemical expertise with innovative approaches to studying serotonin’s physiological roles, influencing the broader field of molecular pharmacology.

đź§Ş Experience

Dr. Kilic has held esteemed academic and research positions, most notably as a professor specializing in biochemistry and cellular molecular biology. She spent significant years at the University of Arkansas for Medical Sciences (UAMS), where she built a robust research program investigating serotonin signaling pathways. Her laboratory became a hub for training future scientists, contributing to key discoveries about SERT’s role in membrane trafficking and its implications for cardiovascular health. Her professional contributions extended to organizing international symposiums and mentoring early-career researchers.

🔍 Research Interests

Dr. Kilic’s research primarily focused on serotonin signaling and transporter mechanisms, particularly the post-translational modifications of SERT. She explored how extracellular 5-HT interacts with plasma membrane-bound SERT across various organ systems during health and disease states. Her studies delved into the glycosylation and oligomerization of SERT, uncovering their impact on membrane trafficking and platelet function. Additionally, she examined the implications of elevated plasma serotonin levels in hypertension, shedding light on the complex interplay between serotonin, platelet physiology, and cardiovascular health.

🏆 Awards

Dr. Kilic’s dedication and contributions have earned her numerous accolades. She received the prestigious Red Sash Award and the Mentor Award from the College of Medicine, recognizing her commitment to education and mentorship. She also chaired the renowned Keystone Symposium “Frontier of Serotonin Beyond the Brain,” highlighting her leadership in the field. These awards reflect her impact not only as a researcher but also as an inspiring mentor and leader in biochemical sciences.

📚Top Noted Publications

Dr. Kilic has authored influential research articles in high-impact journals, advancing our understanding of serotonin signaling:

  • 1. Kilic F., Rudnick G. (2000)Title: Oligomerization of the serotonin transporter and its functional consequences
    Journal: Proceedings of the National Academy of Sciences (PNAS)
    Volume/Issue: 97, pp. 3106-3111
    Key Findings:
    This study explores the oligomeric nature of the serotonin transporter (SERT) and demonstrates that SERT functions in oligomeric complexes. This oligomerization is crucial for proper transport function and regulation.
    Citations: 250+

    2. Li, Y., et al. (2014)

    Title: GDM-associated insulin deficiency hinders SERT dissociation from ERp44
    Journal: Proceedings of the National Academy of Sciences (PNAS)
    Volume/Issue: 111, pp. 52
    Key Findings:
    This research investigates the impact of gestational diabetes mellitus (GDM) on serotonin transporter (SERT) function. It highlights that insulin deficiency linked to GDM interferes with the dissociation of SERT from ERp44, impacting serotonin homeostasis.
    Citations: 180+

    3. Maroteaux L., Kilic, F. (2019)

    Title: Frontiers of Serotonin beyond the brain
    Journal: Pharmacological Research
    Volume/Issue: 140, pp. 1-6
    Key Findings:
    This review discusses the emerging roles of serotonin beyond its traditional neurological functions. It highlights the impact of serotonin in peripheral systems and its potential therapeutic implications.
    Citations: 100+

    4. Lowery III, C. L., Kilic, F. (2019)

    Title: Serotonin and platelet transporter response to smoking
    Journal: Frontiers in Neuroscience
    Volume/Issue: 13, Article 32
    Key Findings:
    The study examines the effects of smoking on serotonin levels and platelet serotonin transporter (SERT) activity. It provides insights into the modulation of peripheral serotonin by smoking, with potential cardiovascular implications.
    Citations: 90+

    5. Brenner, B., et al. (2007)

    Title: Plasma serotonin and platelet serotonin transporter
    Journal: Journal of Neurochemistry
    Volume/Issue: 102(1), pp. 206-216
    Key Findings:
    This research delves into the role of plasma serotonin and the activity of platelet SERT. It underscores the importance of platelet SERT in regulating peripheral serotonin levels and its clinical relevance.
    Citations: 150+

Conclusion

Dr. Fusun Kilic’s extensive research, mentorship, and leadership in serotonin transporter studies position her as a strong candidate for the Best Extension Activity Award. With a focus on translating complex biochemical research into clinical and community applications, her contributions demonstrate significant societal impact. Enhancing the application with concrete examples of public outreach and measurable outcomes will further solidify her case for this prestigious recognition.